Novo Ventures

Novo Ventures

Novo Ventures

Suggest edits
Follow us
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2019
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 13

Portfolio

Portfolio Tracker

Add info
Add round
31 Jul 2019
Alizé Pharma
Alizé Pharma
€67,000,000
Venture capital (Series A)
Life Sciences Partners, Partners Innovation Fund, OrbiMed, +4
20 Sep 2018
Galera Therapeutics
Galera Therapeutics
$150,000,000
Venture capital (Series C)
Adage Capital Management, Correlation Ventures, Novartis Venture Fund, +10

Galera Therapeutics fetches $150 mln Series C

PE HUB
01 Aug 2018
ReViral Ltd
ReViral Ltd
$55,000,000
Venture capital (Series B)
New Leaf Venture Partners, Perceptive Advisors, OrbiMed, +3

ReViral closes $55 million Series B funding round for RSV drug

MedCity News
+2
01 Aug 2018
reViral
reViral
$55,000,000
Venture capital (Series B)
New Leaf Venture Partners, Perceptive Advisors, OrbiMed, +3
29 Jun 2017
Unchained Labs
Unchained Labs
$13,000,000
Venture capital (Series C)
Canaan Partners, TPG Biotech, Novo Ventures

Unchained Labs Gets $13M, Buys Trinean

silicontap
16 Aug 2016
Tioma Therapeutics
Tioma Therapeutics
$86,000,000
Venture capital (Series A)
SR One, Roche Venture Fund, Novo Ventures, +1

Tioma Therapeutics Announces $86 Million Series A Financing

Marketwire
13 May 2014
Ceterix Orthopaedics
Ceterix Orthopaedics
$18,000,000
Venture capital (Series B)
Versant Ventures, 5AM Ventures, Novo Ventures
07 Apr 2014
Alios BioPharma
Alios BioPharma
$41,000,000
Venture capital (Series B)
SR One, Novartis Venture Fund, Roche Venture Fund, +1
07 Mar 2013
Nevro
Nevro
$48,000,000
Venture capital (Series C)
Johnson & Johnson Development Corporation, MPM Capital, NEA, +6
13 Apr 2011
F-star Biotechnology Limited
F-star Biotechnology Limited
$21,739,500
Venture capital
Atlas Venture, MP Healthcare Venture Management, SR One, +4
11 Jun 2009
Alios BioPharma
Alios BioPharma
$8,000,000
Venture capital (Series A)
Novartis Venture Fund, Roche Venture Fund, Novo Ventures
01 Jan 2009
Synosia Therapeutics
Synosia Therapeutics
$29,000,000
Venture capital (Series B)
Investor Growth Capital, Abingworth, Versant Ventures, +4
01 Jan 2006
ProteinSimple
ProteinSimple
$27,000,000
Venture capital (Series B)
Domain Associates, Wellcome Trust, Mitsui & Co. Global Investment, +5